Pharma & Biotech Market Research

In this section you will find information products, including market research reports, on the following sector: Pharma & Biotech

Stay up-to-date with new products added to this category

Results 301 - 400 of 5395 go to 1st page

first

previous 1 2 3 4 5 6 7 8 9 10 11 next

last

Title	Date	Price
NicOx S.A.-Company Report	Sep 2009	£455
Nicogen Inc.-Company Report	Sep 2009	£455
Nippon Chemiphar Co., Ltd.-Company Report	Sep 2009	£455
Nippon Kayaku Co., Ltd.-Company Report	Sep 2009	£455
Nippon Shinyaku Co., Ltd.-Company Report	Sep 2009	£455
Nichi-iko Pharmaceutical Co., Ltd (formerly Nihon Iyakuhin Kogyo Co., Ltd)-Company Report	Sep 2009	£455
N-Gene Research Laboratories, Inc.-Company Report	Sep 2009	£455
NewLink Genetics Corporation-Company Report	Sep 2009	£455
Newron Pharmaceuticals SpA-Company Report	Sep 2009	£455
NexGenix Pharmaceuticals Holdings, Inc.-Company Report	Sep 2009	£455
NextWave Pharmaceuticals-Company Report	Sep 2009	£455
Nippon Zoki Pharmaceutical Co., Ltd.-Company Report	Sep 2009	£455
Nissan Chemical Industries, Ltd.-Company Report	Sep 2009	£455
Noscira, S.A. (formerly Neuropharma, S.A.)-Company Report	Sep 2009	£455
Norwood Immunology Limited-Company Report	Sep 2009	£455
NOVAGALI PHARMA S.A-Company Report	Sep 2009	£455
NovaMed Pharmaceuticals Inc.-Company Report	Sep 2009	£455
Novelix Pharmaceuticals Inc-Company Report	Sep 2009	£455
North China Pharmaceutical Group Corp-Company Report	Sep 2009	£455
Norgine-Company Report	Sep 2009	£455
Nisshin Seifun Group Inc.-Company Report	Sep 2009	£455
Nissui Pharmaceutical Co., Ltd.-Company Report	Sep 2009	£455
Nitec Pharma AG-Company Report	Sep 2009	£455
Nobelpharma Co., Ltd.-Company Report	Sep 2009	£455
Neurotech Pharmaceuticals-Company Report	Sep 2009	£455
NeuroSearch A/S-Company Report	Sep 2009	£455
Nectar Lifesciences Ltd.-Company Report	Sep 2009	£455
Navana Pharmaceuticals Ltd.-Company Report	Sep 2009	£455
Neon Laboratories Ltd.-Company Report	Sep 2009	£455
Neopharma-Company Report	Sep 2009	£455
Neotropix, Inc.-Company Report	Sep 2009	£455
Navamedic ASA-Company Report	Sep 2009	£455
Natural F&P. Inc-Company Report	Sep 2009	£455
Napp Pharmaceuticals Limited-Company Report	Sep 2009	£455
Narhex Life Sciences Ltd-Company Report	Sep 2009	£455
NATCO PHARMA LIMITED-Company Report	Sep 2009	£455
NatImmune A/S-Company Report	Sep 2009	£455
Neovacs SA-Company Report	Sep 2009	£455
Nephron Pharmaceuticals Corporation-Company Report	Sep 2009	£455
NeuroDiscovery Ltd-Company Report	Sep 2009	£455
Neuromed Pharmaceuticals Ltd. (formerly NeuroMed Technologies)-Company Report	Sep 2009	£455
NeuroNova AB-Company Report	Sep 2009	£455
Neuropharm Group plc-Company Report	Sep 2009	£455
Neurim Pharmaceuticals Ltd.-Company Report	Sep 2009	£455
Neuren Pharmaceuticals Limited-Company Report	Sep 2009	£455
Nereus Pharmaceuticals, Inc.-Company Report	Sep 2009	£455
NERVIANO MEDICAL SCIENCES S.r.l.-Company Report	Sep 2009	£455
neuMirRx Corporation-Company Report	Sep 2009	£455
NeurAxon, Inc.-Company Report	Sep 2009	£455
Novell Pharmaceutical Laboratories-Company Report	Sep 2009	£455
Novexel-Company Report	Sep 2009	£455
Ordain Health Care Pvt. Ltd-Company Report	Sep 2009	£455
Orange Drugs Limited-Company Report	Sep 2009	£455
Orexo AB-Company Report	Sep 2009	£455
Organogenesis Inc.-Company Report	Sep 2009	£455
Orient Europharma Co., Ltd.-Company Report	Sep 2009	£455
Onyvax Limited-Company Report	Sep 2009	£455
Onset Therapeutics-Company Report	Sep 2009	£455
Oncoscience AG-Company Report	Sep 2009	£455
Oncosense-Company Report	Sep 2009	£455
Onepharm-Company Report	Sep 2009	£455
Ono Pharmaceutical Co., Ltd.-Company Report	Sep 2009	£455
ORION Laboratories Pty Ltd-Company Report	Sep 2009	£455
Orion Corporation-Company Report	Sep 2009	£455
Otis Clapp and Buffington-Company Report	Sep 2009	£455
Otsuka Pharmaceutical Co., Ltd.-Company Report	Sep 2009	£455
Oxford BioMedica plc-Company Report	Sep 2009	£455
Oxagen Limited-Company Report	Sep 2009	£455
Othera Pharmaceuticals, Inc.-Company Report	Sep 2009	£455
Osmotica Pharmaceutical Corp.-Company Report	Sep 2009	£455
Orivas-Company Report	Sep 2009	£455
ORLING spol. s r.o.-Company Report	Sep 2009	£455
Ortho-McNeil, Inc.-Company Report	Sep 2009	£455
Ortin Laboratories Limited-Company Report	Sep 2009	£455
Onconova Therapeutics Inc.-Company Report	Sep 2009	£455
OncoMune, LLC-Company Report	Sep 2009	£455
Oboi Laboratories-Company Report	Sep 2009	£455
Oakwood Laboratories, L.L.C.-Company Report	Sep 2009	£455
Ocera Therapeutics, Inc.-Company Report	Sep 2009	£455
Octapharma AG-Company Report	Sep 2009	£455
OctoPlus N.V.-Company Report	Sep 2009	£455
Nuvo Research Inc. (formerly Dimethaid Research Inc.)-Company Report	Sep 2009	£455
Numerate, Inc.-Company Report	Sep 2009	£455
Novopharm Limited-Company Report	Sep 2009	£455
NOXXON Pharma AG-Company Report	Sep 2009	£455
NTC S.r.L.-Company Report	Sep 2009	£455
Nucitec, S.A. de C.V.-Company Report	Sep 2009	£455
Odan Laboratories Ltd-Company Report	Sep 2009	£455
Oftalmoquimica Ltda.-Company Report	Sep 2009	£455
Omeros Corporation-Company Report	Sep 2009	£455
OMNINVEST Vaccine Manufacturing, Researching and Trading Ltd-Company Report	Sep 2009	£455
Omrix Biopharmaceuticals Inc-Company Report	Sep 2009	£455
Oncolys Biopharma Inc.-Company Report	Sep 2009	£455
OmegaGenesis-Company Report	Sep 2009	£455
Omega Laboratories Limited-Company Report	Sep 2009	£455
Okairos S.r.l.-Company Report	Sep 2009	£455
Okopharm GmbH-Company Report	Sep 2009	£455
OM PHARMA-Company Report	Sep 2009	£455
Omega Pharma NV-Company Report	Sep 2009	£455
Ozone Pharmaceuticals Ltd.-Company Report	Sep 2009	£455